Weekly TP-HDFL in the Treatment of Advanced TCC
NCT00154687
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Transitional Cell Carcinoma
Interventions
DRUG:
Paclitaxel, Cisplatin, 5-Fluorouracil
Sponsor
National Taiwan University Hospital